Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Gynecologic Oncology|September 10, 2015
Canadian high risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancersAlon D Altman, Sarah E Ferguson, Eshetu G Atenafu, et al.
British Journal of Haematology|October 11, 2014
A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosisKevin H M Kuo, Jeannie L Callum, Tony Panzarella, et al.
Blood Advances|January 4, 2018
Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapyJay Y Spiegel, Caroline McNamara, James A Kennedy, et al.
European Journal of Haematology|April 22, 2026
Impact of Modern Strategies for Graft-Versus-Host Disease Prophylaxis on Relapse Risk in Matched-Sibling or Unrelated Donor Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis of Randomized TrialsLeonardo Javier Arcuri, Victor Hugo Glasser Natal, André Dias Américo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2014
Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphomaDiego Villa, Anupkumar George, John F Seymour, et al.
Blood Advances|October 18, 2018
The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomesCaroline J McNamara, Tony Panzarella, James A Kennedy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2013
Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant groupDiego Villa, Michael Crump, Tony Panzarella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2017
Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular CharacterizationStephanie Lheureux, Zhongwu Lai, Brian A Dougherty, et al.
Haematologica|September 23, 2017
CD56<sup>bright</sup> natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-<i>versus</i>-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study resultsAmina Kariminia, Sabine Ivison, Bernard Ng, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 8, 2016
Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group StudyStephen Couban, Mahmoud Aljurf, Sylvie Lachance, et al.
Pageof 9